Company Update (NYSE:BAX): Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook

[Business Wire] – Baxter International Inc. today reported results for the fourth quarter of 2015 that exceeded the company’s previously issued guidance. Read more on this. Baxter International Inc. (BAX) , valued at $20.26B, opened this morning at $37.50. Shares have traded today between $36.37 and $37.63 per share with a trailing 52-week range being $32.18 to $43.44. BAX shares are currently priced at 29.59x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s 4.59x earnings multiple. And for dividend hunters, the company pays shareholders $0.46 per share annually in dividends, yielding 1.26%. According to a consensus of 14 analysts, the earnings estimate of $0.32 per share would be $0.04 better than the year-ago quarter and a $0.01 sequential increase. The full-year EPS estimate is $1.26, which would be a $0.02 better than last year. The quarterly earnings estimate is predicated on a consensus revenue forecast of $2.55 Billion. If reported, that would be a 42.95% decrease over the year-ago quarter. Recently, Leerink Partners downgraded BAX from Outperform to Mkt Perform (Jul 30, 2015). Previously, BofA/Merrill downgraded BAX from Buy to Neutral. The average price target for BAX shares is $39.20, which is 4.53% above where the stock opened this morning. See more in (NYSE:BAX) Similar Articles: Company Update: Baxter International Inc (NYSE:BAX) – Baxter to Present at The Leerink Partners 5th Annual Global Healthcare Conference Company Update (NYSE:BAX): Baxter International Fourth Quarter 2015 Financial Results Conference Call Company Update: Baxter International Inc (NYSE:BAX) – Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.